Sanofi Ventures
Sanofi Ventures is the strategic venture capital arm of Sanofi, one of the world's largest pharmaceutical companies. The fund invests in innovative biotechnology and healthcare companies across therapeutic areas, with a focus on breakthrough science that could transform patient outcomes.
Location
Cambridge, Massachusetts, USA
Founded
2018
AUM
$700M+
Investment Range
$5M - $50M
Portfolio Companies
1
Focus
cvc
Fund Stages
seed, series-a, series-b, series-c, growth
Investment Thesis
Sanofi Ventures invests in cutting-edge biotechnology companies developing novel therapeutics across immunology, oncology, rare diseases, and vaccines. The fund provides strategic value beyond capital, offering portfolio companies access to Sanofi's global resources, scientific expertise, and commercial capabilities.
Team
Partners / Managing Directors
- Rainer Boehm, MD - Global Head of Sanofi Ventures
- Laurent Choppe - Managing Director
- Milind Kamkolkar - Managing Director
Other Key Team Members
- Olivier Blum - Investment Director
Focus Areas
- Immunology
- Oncology
- Rare Diseases
- Vaccines
- Neurology
- Gene Therapy
- Cell Therapy
Notable Portfolio Companies
- Mirador Therapeutics - Precision medicines for immune-related diseases
- Kymera Therapeutics - Targeted protein degradation (IPO 2020)
- Generation Bio - Non-viral gene therapy
- Passage Bio - Gene therapies for CNS disorders
Notable Exits
- Kymera Therapeutics - IPO (2020, NASDAQ: KYMR)
- Passage Bio - IPO (2020, NASDAQ: PASG)
- Chinook Therapeutics - Acquired (2023, acquired by Novartis for $3.2B)
Sources
- Sanofi Ventures: https://www.sanofi.com/en/partnering/sanofi-ventures
- Crunchbase: https://www.crunchbase.com/organization/sanofi-ventures
- PitchBook profile
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| Mirador Therapeutics | San Diego, California, USA | 2023 | therapeuticsbiotech+3 |